November 13, 2024
2 min watch
Save
VIDEO: Vevye offers improved bioavailability, rapid onset, minimal side effects
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
INDIANAPOLIS — In this Healio video, Kaleb Abbott, OD, MS, FAAO, assistant professor at University of Colorado School of Medicine, discusses three things optometrists should know about Vevye for dry eye.
“The first is improved bioavailability,” Abbott said, explaining that the product’s vehicle, perfluorobutylpentane, improves delivery through the tear film.
Vevye (cyclosporine ophthalmic solution 0.1%; Harrow) also has rapid onset of action and minimal side effects, he noted.
“In fact, 99.8% of patients in the clinical trials either had none or only mild ... pain when they were instilling the drop,” Abbott said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Abbott reports consulting for Bausch + Lomb, Dompe, Harrow, Optase and Tarsus.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.